NAA10 Human Pre-designed siRNA Set A contains three designed siRNAs for NAA10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAA15 Human Pre-designed siRNA Set A contains three designed siRNAs for NAA15 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAA16 Human Pre-designed siRNA Set A contains three designed siRNAs for NAA16 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAA20 Human Pre-designed siRNA Set A contains three designed siRNAs for NAA20 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAA30 Human Pre-designed siRNA Set A contains three designed siRNAs for NAA30 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAA40 Human Pre-designed siRNA Set A contains three designed siRNAs for NAA40 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAA50 Human Pre-designed siRNA Set A contains three designed siRNAs for NAA50 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAA60 Human Pre-designed siRNA Set A contains three designed siRNAs for NAA60 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAAA Human Pre-designed siRNA Set A contains three designed siRNAs for NAAA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAALAD2 Human Pre-designed siRNA Set A contains three designed siRNAs for NAALAD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAALADL2 Human Pre-designed siRNA Set A contains three designed siRNAs for NAALADL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAB1 Human Pre-designed siRNA Set A contains three designed siRNAs for NAB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAB2 Human Pre-designed siRNA Set A contains three designed siRNAs for NAB2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NABP1 Human Pre-designed siRNA Set A contains three designed siRNAs for NABP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NACA Human Pre-designed siRNA Set A contains three designed siRNAs for NACA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NACA2 Human Pre-designed siRNA Set A contains three designed siRNAs for NACA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NACAD Human Pre-designed siRNA Set A contains three designed siRNAs for NACAD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NACC1 Human Pre-designed siRNA Set A contains three designed siRNAs for NACC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NACC2 Human Pre-designed siRNA Set A contains three designed siRNAs for NACC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NADH disodium salt (Disodium NADH) hydrate is an orally active reduced coenzyme. NADH disodium salt hydrate is a donor of ADP-ribose units in ADP-ribosylaton reactions and a precursor of cyclic ADP-ribose. NADH disodium salt hydrate plays a role as a regenerative electron donor in cellular energy metabolism, including glycolysis, β-oxidation and the tricarboxylic acid (TCA) […]

NADK Human Pre-designed siRNA Set A contains three designed siRNAs for NADK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NADK2 Human Pre-designed siRNA Set A contains three designed siRNAs for NADK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NADSYN1 Human Pre-designed siRNA Set A contains three designed siRNAs for NADSYN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAE-IN-1 (compound X-10) is a potent NAE1 inhibitor. NAE-IN-1 induces apoptosis and cell cycle arrest at the G2/M phase. NAE-IN-1 increases ROS levels and prevents cell migration. NAE-IN-1 shows anti-proliferation activity[1].

NAE1 Human Pre-designed siRNA Set A contains three designed siRNAs for NAE1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAF1 Human Pre-designed siRNA Set A contains three designed siRNAs for NAF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nafoxidine, a nonsteroidal estrogen antagonist, is shown to possess antitumor activity against breast cancer.

NAGA Human Pre-designed siRNA Set A contains three designed siRNAs for NAGA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAGK Human Pre-designed siRNA Set A contains three designed siRNAs for NAGK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAGLU Human Pre-designed siRNA Set A contains three designed siRNAs for NAGLU gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAGPA Human Pre-designed siRNA Set A contains three designed siRNAs for NAGPA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAGS Human Pre-designed siRNA Set A contains three designed siRNAs for NAGS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAIP Human Pre-designed siRNA Set A contains three designed siRNAs for NAIP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nalanthalide is a voltage-gated potassium channel Kv1.3 blocker (IC50=3.9 µM) and a potential immunosuppressant. Nalanthalide can be used for research on inflammatory immune diseases, such as neuroinflammation[1][2].

NALCN Human Pre-designed siRNA Set A contains three designed siRNAs for NALCN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Naloxegol (NKTR-118; AZ-13337019) is a μ-opioid-receptor antagonist. Naloxegol inhibits opioid binding in μ-opioid receptors in the gastrointestinal tract and effective for alleviating opioid-induced constipation[1][2].

Naloxegol oxalate (NKTR-118 oxalate; AZ-13337019 oxalate) is a μ-opioid-receptor antagonist. Naloxegol oxalate inhibits opioid binding in μ-opioid receptors in the gastrointestinal tract and effective for alleviating opioid-induced constipation[1][2].

Naloxegol oxalate (NKTR-118 oxalate; AZ-13337019 oxalate) is a μ-opioid-receptor antagonist. Naloxegol oxalate inhibits opioid binding in μ-opioid receptors in the gastrointestinal tract and effective for alleviating opioid-induced constipation[1][2].

Naloxegol oxalate (NKTR-118 oxalate; AZ-13337019 oxalate) is a μ-opioid-receptor antagonist. Naloxegol oxalate inhibits opioid binding in μ-opioid receptors in the gastrointestinal tract and effective for alleviating opioid-induced constipation[1][2].

Namirotene (CBS-211A) is a retinoic acid analog, which is utilized in topical eye administration. Namirotene enhances 1α,25-dihydroxyvitamin D3-induced cytotoxicity in cell U937 and induces the differentation in U937[1].

Nampt activator-5 (compound C8) is a potent nicotinamide phosphoribosyltransferase (NAMPT) activator with a KD value of 6.19 µM. Nampt activator-5 shows a cellular antisenescence effect. Nampt activator-5 promotes the production of NAD+ in the brain and reduces the expression of age-related markers and secretory phenotypes. Nampt activator-5 has the potential for the research of age-related […]

NAMPT activator-7 (Compound 232) is an activator for nicotinamide phosphoribosyltransferase (NAMPT), with EC50 < 0.5 μM. NAMPT activator-7 activates NAMPT in cells U2OS with cellular EC50 of < 0.5 μM[1].

NAMPT activator-8 (Compound 278) is an activator for nicotinamide phosphoribosyltransferase (NAMPT), with EC50 < 0.5 μM. NAMPT activator-8 activates NAMPT in cells U2OS with cellular EC50 of < 0.5 μM[1].

NAMPT Human Pre-designed siRNA Set A contains three designed siRNAs for NAMPT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nampt Mouse Pre-designed siRNA Set A contains three designed siRNAs for Nampt gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nampt Rat Pre-designed siRNA Set A contains three designed siRNAs for Nampt gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

NANOG Human Pre-designed siRNA Set A contains three designed siRNAs for NANOG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.